期刊文献+

COPD营养不良与细胞因子的关系及消炎痛干预实验研究 被引量:10

Relationship of Cytokine Level with Malnutrition of Chronic Obstructive Pulmonary Disease and Therapeutic Effects of Indomethacin
下载PDF
导出
摘要 【目的】探讨慢性阻塞性肝疾病(COPD)营养不良与细胞因子的关系及消炎痛对COPD营养不良的影响。【方法】按气管内滴内毒素和熏香烟法建立COPD大鼠模型,选择营养不良COPD大鼠予以消炎痛干预,检测干预前后营养指标及血清TNF-α、IL-1β的变化,并与生理盐水对照组比较。【结果】消炎痛干预后血清TNF-α、IL-1β水平明显降低,体重、血浆白蛋白、血浆甘油三酯明显升高,血糖明显下降。【结论】消炎痛通过抑制血清TNF-α、IL-1β的升高可以改善COPD营养不良大鼠的营养状况。 [Objective]To explore relationship of cytokine level with malnutrition of rats with Chronic Obstructive Pulmonary Disease (COPD) and therapeutic effects of indomethacin for malnutrition of COPD. [Methods]The rats COPD models were established by intratracheal instillation of lipopolysaccharide (200μg/ 100μl) twice and exposed to cigarette smoke for four weeks, 30 min per day. Indomethacin intervention group was abdominally injected indomethacin (0.7mg/kg), the intervention duration was 10 days. Serum albumin, glucose.triglyceride. TNF-α, IL-1β levels and body weight of different groups in different stages were measured and compared. [Results]After intervention with indomethacin, the intervention group showed higher serum albumin, triglyceride and body weight levels, lower serum TNF-α, IL-1β glucose levels than group without intervention and the saline control group. The difference was significant. [Conclusion]Indomethacin may improve the nutritional status of malnutrished COPD rats by inhibiting the growth factors of cytokine TNF-α, IL-1β.
出处 《医学临床研究》 CAS 2006年第10期1572-1574,1577,共4页 Journal of Clinical Research
关键词 肺疾病 阻塞性 营养障碍 生物因子 吲哚美辛 lung diseases, obstructive nutrition disorders biological factors indomethacin
  • 相关文献

参考文献9

  • 1Landbo C,Prescott E,Lange P,et al.Prognostic value of nutritional status in chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,1999,160(6):1856-1861.
  • 2宋一平,崔德健,茅培英,梁延杰,王德文.慢性阻塞性肺疾病大鼠模型气道重塑及生长因子的研究[J].中华结核和呼吸杂志,2001,24(5):283-287. 被引量:123
  • 3Pfitzenmaier J,Vessella R.Elevation of cytokine levels in cachectic patients with prostate carcinoma[J].Cancer,2003,97(5):1211-1216.
  • 4Pitsiou G,Kyriazis O,Hatzizisi P,et al.Tumor necrosis factor-alpha serum levels,weight loss and tissue oxygenation in chronic obstructive pulmonary disease[J].Respiratory Medicine,2002,96(8):594-598.
  • 5于康.临床营养学[M].北京:中国协和医科大学出版社,2003.222-226.
  • 6Jakobsson P,Jorfeldt L,von Schenck H.Insulin resistance is not exhibited by advanced chronic obstructive pulmonary disease patients[J].Clin Physiol,1995,15(6):547-555.
  • 7Ferreira IM,Brooks D,Lacasse Y,et al.Nutritional support for individuals with COPD a meta-analysis[J].Chest,2000,117:672-678.
  • 8牛旗,李同度,刘爱国,董慧明,宋德胜.细胞因子在实验性癌症恶病质中的作用[J].中华肿瘤杂志,2001,23(5):382-384. 被引量:7
  • 9徐建芳,周彩存,张海平,粟波,唐亮,成倍玲,秦萍,李爱武.癌症恶病质与细胞因子的关系及消炎痛干预的实验研究[J].中国肺癌杂志,2004,7(4):336-338. 被引量:6

二级参考文献18

  • 1Strassmann G, Masui Y, Chizzonite R, et al. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26tumor. J Immunol,1993,150(6): 2341-2345.
  • 2Darling G, Fraker DL, Jensen JC, et al. Cachectic effects of recombinant human tumor necrosis factor in rats. Cancer Res, 1990, 50(13): 4008-4013.
  • 3Tessitore L, Costelli P, Baccino FM. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer,1993,67(1): 15-23.
  • 4Yasumoto K, Mukaida N, Harada A, et al. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcino ma-bearing mice. Cancer Res,1995,55(4): 921-927.
  • 5Mori K, Fujimoto Ouchi K, Ishikawa T, et al. Murine interleukin12 prevents the development of cancer cachexia in a murine model.Int J Cancer,1996,67(6) : 849-855.
  • 6Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res,1994,54(21): 5602-5606.
  • 7Strassmann G, Fong M, Kenney JS, et al. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest,1992,89(5): 1681-1684.
  • 8Espat NJ, Moldawer LL, Copeland EM 3rd. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients. J Surg Oncol, 1995,58(2): 77-82.
  • 9Langstein HN,Norton JA.Mechanisms of cancer cachexia[].Hematology Oncology Clinics of North America.1991
  • 10Espat NJ,Lyle LM,Moldawer S,et al.Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients[].Journal of Surgical Oncology.1995

共引文献133

同被引文献95

引证文献10

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部